King Law Is Investigating Ozempic Claims Related to Severe Side Effects Allegedly Caused by Ozempic Our Ozempic Legal Team at King Law Contact an Ozempic Lawyer Today Key Takeaways Heres some key information about the Ozempic lawsuits: There are more than 3,700 claims across two MDLs filed since the litigation began in 2024 (the MDLs also include lawsuits for those injured by Wegovy, Mounjaro, and other GLP-1 drugs) Key legal claims against Novo Nordisk include failure to warn, negligence, negligent marketing, and product liability (for a pharmaceutical drug) Defendants are Novo Nordisk and Eli Lilly (which makes other GLP-1 drugs) There are two MDLs for the Ozempic injury claims: Number of pending claims in MDL 3094 as of July 1, 2026: 3,848 Number of pending claims in MDL 3163 as of July 1, 2026: 146 People can file individual Ozempic lawsuits or join the active MDLs The Honorable Karen S
Furthermore, cardiovascular disease risk can accumulate silently over time
J.ThimmulappaR
This means fewer food-focused thoughts and less temptation to give in to unhealthy cravings
There have also been concerns raised in the scientific literature regarding cardiovascular safety
The therapeutic utility of native GLP-1 is limited by its rapid degradation [2], primarily mediated by dipeptidyl peptidase-4 (DPP-4) and secondarily by neutral endopeptidases (NEPs) and renal clearance [3, 4]
